In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Naia Ltd.

www.naiapharma.com

Latest From Naia Ltd.

The NASH Pipeline: Replete With Targets And New Compounds

The numerous different targets of investigational drugs for the treatment of NASH suggest the jury is still out on which mechanism of action is most likely to prove effective against the condition. Ireland’s Afimmune is the latest company wanting to advance an investigational drug for the disorder into late-stage clinical studies.

Liver & Hepatic Market Intelligence

Start-Up Execs On The Move, May 2015

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Start-Up Quarterly Statistics, Q1 2015

In Q1 2015 start-ups raised $2.74 billion, a new record. Biopharma companies penned 37 alliances; 13 start-ups were acquired across all industries.

BioPharmaceutical Medical Device

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Caribbean
        • Cayman Islands
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Naia Ltd.
  • Senior Management
  • H. Daniel Perez, MD, Chmn. & CEO
    Mark Bagnall, CFO & COO
    David N Chernoff, MD, CMO
  • Contact Info
  • Naia Ltd.
    ,
    Cayman Islands
Advertisement
Advertisement
UsernamePublicRestriction

Register